Andreas Teufel

15.5k total citations · 1 hit paper
184 papers, 6.6k citations indexed

About

Andreas Teufel is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Andreas Teufel has authored 184 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 53 papers in Molecular Biology and 52 papers in Epidemiology. Recurrent topics in Andreas Teufel's work include Liver Disease Diagnosis and Treatment (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease and Transplantation (18 papers). Andreas Teufel is often cited by papers focused on Liver Disease Diagnosis and Treatment (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Liver Disease and Transplantation (18 papers). Andreas Teufel collaborates with scholars based in Germany, United States and Switzerland. Andreas Teufel's co-authors include Peter Riederer, Klaus‐Peter Lesch, Dietmar Bengel, Armin Heils, Susanne Petri, Peter R. Galle, Jens U. Marquardt, R. Schlickeiser, Heiner Westphal and Stephan Kanzler and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Andreas Teufel

174 papers receiving 6.5k citations

Hit Papers

Allelic Variation of Huma... 1996 2026 2006 2016 1996 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Andreas Teufel 2.2k 1.4k 1.2k 1.1k 931 184 6.6k
Aart J. Nederveen 1.5k 0.7× 2.0k 1.4× 564 0.5× 586 0.6× 346 0.4× 408 11.6k
Tomio Inoue 1.2k 0.6× 1.2k 0.9× 500 0.4× 677 0.6× 1.3k 1.4× 515 10.5k
Д. А. Шапиро 1.5k 0.7× 2.2k 1.5× 1.5k 1.3× 871 0.8× 1.5k 1.6× 178 7.3k
Georg Brabant 3.5k 1.6× 2.3k 1.6× 167 0.1× 495 0.5× 989 1.1× 348 15.4k
Àlex Rovira 1.8k 0.8× 3.1k 2.2× 838 0.7× 845 0.8× 1.3k 1.4× 408 16.3k
Kiyoshi Maeda 2.8k 1.3× 491 0.3× 226 0.2× 1.2k 1.1× 3.4k 3.6× 481 9.8k
Massimiliano Copetti 2.0k 0.9× 941 0.7× 214 0.2× 739 0.7× 512 0.5× 309 9.5k
Val J. Lowe 2.7k 1.3× 1.3k 0.9× 298 0.2× 1.3k 1.2× 1.5k 1.6× 586 26.1k
Hiroshi Oka 2.4k 1.1× 717 0.5× 574 0.5× 693 0.7× 1.3k 1.4× 368 7.2k
Ian Everall 2.8k 1.3× 712 0.5× 119 0.1× 2.0k 1.9× 311 0.3× 217 10.4k

Countries citing papers authored by Andreas Teufel

Since Specialization
Citations

This map shows the geographic impact of Andreas Teufel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Teufel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Teufel more than expected).

Fields of papers citing papers by Andreas Teufel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Teufel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Teufel. The network helps show where Andreas Teufel may publish in the future.

Co-authorship network of co-authors of Andreas Teufel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Teufel. A scholar is included among the top collaborators of Andreas Teufel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Teufel. Andreas Teufel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Tianzuo, Johannes Betge, Nadine Schulte, et al.. (2025). Digestive cancers: mechanisms, therapeutics and management. Signal Transduction and Targeted Therapy. 10(1). 24–24. 14 indexed citations
2.
Bantel, Heike, Marcos Girala, Matthias P. Ebert, et al.. (2024). Evaluation of four chatbots in autoimmune liver disease: A comparative analysis. Annals of Hepatology. 30(1). 101537–101537. 6 indexed citations
3.
Teufel, Andreas, et al.. (2024). Current Trends and Advancements in the Management of Hepatocellular Carcinoma. Digestive Diseases. 42(4). 349–360. 5 indexed citations
4.
Navas, María Cristina, et al.. (2024). Prevention in Hepatology. Journal of Personalized Medicine. 14(2). 132–132.
5.
Teufel, Andreas, Andreas Geier, Christoph Sarrazin, et al.. (2023). Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD). Zeitschrift für Gastroenterologie. 61(8). 1028–1036. 1 indexed citations
6.
Vogel, Arndt, Oliver Waidmann, Tobias Müller, et al.. (2023). IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 41(4_suppl). 555–555. 4 indexed citations
7.
Teufel, Andreas, et al.. (2023). Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort. Journal of Gastrointestinal and Liver Diseases. 32(2). 190–196. 5 indexed citations
8.
9.
Hsiau, Shu‐San, et al.. (2022). Discovery and study of abrasion behavior in granular shear flow. Journal of Mechanics. 38. 367–375. 2 indexed citations
10.
Ludwig, Sonja, et al.. (2022). Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance. Viruses. 14(5). 849–849. 20 indexed citations
11.
Itzel, Timo, et al.. (2022). Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers. Cancers. 14(17). 4322–4322. 2 indexed citations
12.
Scheiter, Alexander, Katja Evert, Antonio Cigliano, et al.. (2021). RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues. Molecular Oncology. 16(5). 1091–1118. 12 indexed citations
13.
Itzel, Timo, et al.. (2021). Prognostic Cancer Gene Expression Signatures: Current Status and Challenges. Cells. 10(3). 648–648. 60 indexed citations
14.
Dietrich, Christoph F., Long Shi, Axel Löwe, et al.. (2021). Conventional ultrasound for diagnosis of hepatic steatosis is better than believed. Zeitschrift für Gastroenterologie. 60(8). 1235–1248. 17 indexed citations
15.
Dietrich, Peter, Valerie Fritz, Tatjana Seitz, et al.. (2020). Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. Journal of Clinical Investigation. 130(5). 2509–2526. 34 indexed citations
16.
Vick, Binje, Achim Weber, Toni Urbanik, et al.. (2008). Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes #. Hepatology. 49(2). 627–636. 125 indexed citations
17.
Teufel, Andreas, I. Lerche, & R. Schlickeiser. (2003). Cosmic ray transport in anisotropic magnetohydrodynamic turbulence. Astronomy and Astrophysics. 397(3). 777–788. 11 indexed citations
18.
Teufel, Andreas & R. Schlickeiser. (2002). Analytic calculation of the parallel mean free path of heliospheric cosmic rays. Astronomy and Astrophysics. 393(2). 703–715. 64 indexed citations
19.
Teufel, Andreas & R. Schlickeiser. (2002). Analytic calculation of the parallel mean free path of heliospheric cosmic rays. Astronomy and Astrophysics. 397(1). 15–25. 91 indexed citations
20.
Clément, David, Erich W. Schmid, & Andreas Teufel. (1974). Positive energy bound states in resonating group calculations. Physics Letters B. 49(4). 308–310. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026